Hauser Plans to Divest Hauser Laboratories; Division Provides Analytical and Expert Services to Biopharm, Neutraceutical, Medical Device and Pipeline Industries


BOULDER, Colo., Aug. 21, 2001 (PRIMEZONE) -- Hauser, Inc. (OTCBB:HAUS) announced today it has retained Oberman Associates Inc. to manage the sale of its Hauser Laboratories division.

Hauser Laboratories provides analytical and expert services to meet the advanced chemical and material needs of biopharmaceutical, infrastructure and electronics industries. Hauser Laboratories is established as a leader in the development of analytical standards for nutraceuticals and medical devices. It also provides methods development, testing and failure analysis for pipelines and cables, fuels and contaminants, and industrial and consumer products.

Hauser Laboratories is located in Boulder, Colorado.

"The sale will permit Hauser to focus its resources on the production and marketing of bulk herbal extracts and nutritional substances. We believe that there are other parties that can realize greater value given from Hauser Laboratories, leveraging its sector leadership, proprietary analytical and validation methods, and customer relationships," according to Kenneth Cleveland, Hauser's president and chief executive officer.

Hauser, a Customer Connected(SM) company headquartered in Boulder, Colorado, is a leading supplier of herbal extracts and nutritional supplements. The company also provides interdisciplinary laboratory testing services, chemical engineering services, and contract research and development. The company's products and services are principally marketed to the pharmaceutical, dietary supplement and food ingredient businesses. Hauser's business units include: Botanicals International Extracts; Hauser Laboratories; Shuster Laboratories; and ZetaPharm.

Certain oral and written statements of management of the Company included in this Press Release and elsewhere may contain forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. These statements include the plans and objectives of management for future operations. The forward-looking statements included herein and elsewhere are based on current expectations that involve judgments which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the forward-looking statements will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements, the inclusion of such information should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved.



            

Contact Data